Canada markets closed

WPD Pharmaceuticals Inc. (WPDPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 12:34PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 22.69k
Enterprise Value 126.07k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)107.84
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.01

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 30.00%
S&P500 52-Week Change 323.10%
52 Week High 30.0002
52 Week Low 30.0000
50-Day Moving Average 30.0002
200-Day Moving Average 30.0002

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5113.44M
Implied Shares Outstanding 618.94B
Float 8N/A
% Held by Insiders 139.62%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -230.98k
Net Income Avi to Common (ttm)5.97M
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)143.46k
Total Cash Per Share (mrq)0
Total Debt (mrq)283.26k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.36
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-889.79k
Levered Free Cash Flow (ttm)N/A